LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
$ 398,000
Employment & Personnel Businesses for Sale
Gift & Flower Shops for Sale
Farms & Vineyards for Sale
Automotive Businesses for Sale
Clothing & Shoe Stores for Sale
Fitness & Wellness Businesses for Sale
Liquor Store Businesses for Sale
Beauty & Personal Care Businesses for Sale
Coffee Shop, Bakery & Dessert Businesses for Sale
Advertising & Promotional Businesses for Sale
Laundromat & Dry Cleaning Franchise Opportunities
Retail Franchise Opportunities
Clothing & Shoe Store Franchise Opportunities
Gift & Flower Shop Franchise Opportunities
Fitness & Wellness Franchises for Sale
Service Franchises for Sale
Warehouse & Storage Franchise for Sale
Smoke & Vape Shop Franchises for Sale
Coffee, Bakery & Dessert Franchise Opportunities
Vending & Kiosk Franchises for Sale
Land & Developments for Sale
Mixed Use Buildings for Sale or Rent
Commercial Spaces for Sale or Lease
Retail Buildings for Sale or Lease
Houses & Condos for Sale or Lease
Medical Buildings for Sale or Lease
Miscellaneous Properties for Sale or Lease
Industrial Units for Sale or Rent
Apartment Buildings for Sale
Warehouses for Sale or Lease
An email will be sent to registered email address.
Please select if you are: